AGER and breast cancer: On the other hand, the systemic glucose-lowering ability of Ins was not restrained by FPS-ZM1 in our allograft animal model, thus suggesting that the obliteration of RAGE signaling in hyperinsulinemic BC patients could be pursued without obtaining diabetic-like responses.